Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

37.41
Delayed Data
As of Feb 05
 -0.60 / -1.58%
Today’s Change
36.00
Today|||52-Week Range
51.74
-16.70%
Year-to-Date

Today’s Trading

Previous close38.01
Today’s open38.23
Day’s range37.12 - 38.35
Volume5,750,213
Average volume (3 months)7,304,778
Market cap$55.8B
Dividend yield2.78%
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+18.58%
Earnings growth (this year)+0.56%
Earnings growth (next 5 years)+10.45%
Revenue growth (last year)+0.78%
P/E ratio22.2
Price/Sales3.31
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.44-1.44%
CELGCelgene-4.04-3.96%
VRXValeant Pharmaceutic...-0.35-0.36%
ALXNAlexion Pharmaceutic...-3.74-2.56%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 13, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts

Partner Offers